Log in or Sign up for Free to view tailored content for your specialty!
Gastrointestinal Cancer News
SVR improves overall survival, lowers risk of recurrence of HCC
HONOLULU — Patients with hepatitis C virus infection who achieved a sustained virologic response after curative treatment for hepatocellular carcinoma had increased overall survival with a decreased rate of recurrence, according to findings presented at ACG 2015.
Diabetes, metabolic syndrome increase risk for HCC
HONOLULU — Researchers from Penn State Milton S. Hershey Medical Center found that diabetes and metabolic syndrome were independent risk factors for the development of hepatocellular carcinoma, according to data presented during a plenary session at ACG 2015.
Log in or Sign up for Free to view tailored content for your specialty!
ACS issues new care guidelines for survivors of colorectal cancer
The American Cancer Society has issued cancer survivorship care guidelines for providing comprehensive care to survivors of colorectal cancer.
Tigatuzumab/Nexavar combination fails to improve advanced HCC
Researchers found that tigatuzumab in combination with Nexavar was not effective in treating patients with advanced hepatocellular carcinoma, according to phase 2 clinical trial data published in the Journal of Hepatology.
Vitamin D, calcium do not reduce risk for colorectal adenomas
Daily supplementation with vitamin D, calcium or both did not significantly decrease risk for recurrent colorectal adenomas, according to the results of a randomized, double blind, placebo-controlled trial.
Older individuals with one relative with CRC may not need aggressive screening
A recent study found only a small increase in risk for colorectal cancer incidence and death among older individuals who have only one first-degree relative diagnosed with colorectal cancer, leading researchers to conclude that current guidelines should be adjusted.
EMA grants orphan drug designation to CF102 for HCC
The European Medicines Agency has granted orphan drug designation to Can-Fite BioPharma Ltd.’s CF102, a potential drug to treat hepatocellular carcinoma, according to a press release.
Ablative therapies show promise for advanced pancreatic cancer
The addition of irreversible electroporation to conventional chemotherapy and radiation therapy appears to improve survival outcomes in patients with locally advanced pancreatic adenocarcinoma, according to the results of a registry study.
What are tyrosine kinase inhibitors?
Elevated levels of tyrosine kinases are observed in certain types of cancer cells.
What is hormone therapy?
Hormone therapy is most commonly used to treat symptoms of menopause, including hot flashes, night sweats, osteoporosis, mood swings and sleep disorders.
-
Headline News
New stroke primary prevention guideline calls for more screening of risk factors
October 21, 20243 min read -
Headline News
Bariatric surgery more cost-effective than GLP-1s in long term
October 21, 20242 min read -
Headline News
Study: Infant deaths rose 7% after Dobbs decision
October 21, 20242 min read
-
Headline News
New stroke primary prevention guideline calls for more screening of risk factors
October 21, 20243 min read -
Headline News
Bariatric surgery more cost-effective than GLP-1s in long term
October 21, 20242 min read -
Headline News
Study: Infant deaths rose 7% after Dobbs decision
October 21, 20242 min read